Apogenix GmbH, develops drugs that are based on the targeted modulation of CD95 and Interleukin-4 receptor mediated signaling pathways.
Business Model:
Revenue: $5M
Employees: 51-500
Address: Im Neuenheimer Feld 584
City: Heidelberg
State: baden-württemberg
Zip: 69120
Country: DE
Apogenix GmbH, develops drugs that are based on the targeted modulation of CD95 and Interleukin-4 receptor mediated signaling pathways.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 12/2021 | Equity | $29.2M |
dievini Hopp Biotech Holding |
2/2016 | Grant | $3.3M |
Federal Ministry of Education and Research |
1/2012 | Series C | $9.8M |
Dievini Hopp BioTech holding GmbH & Co. KG German Cancer Research Center |
4/2008 | Series B | 1 | $42.9M |
dievini Hopp Biotech Holding dievini Hopp Biotech Holding |
2/2016 | Grant | 1 | $3.3M |
German Federal Ministry of Education and Research (BMBF) German Federal Ministry of Education and Research (BMBF) |
2/2012 | Series C | 1 | $10.1M |
dievini Hopp Biotech Holding dievini Hopp Biotech Holding |
2/2016 | Grant | 1 | $3.3M |
German Federal Ministry of Education and Research (BMBF) German Federal Ministry of Education and Research (BMBF) |
2/2012 | Series C | 1 | $10.1M |
dievini Hopp Biotech Holding dievini Hopp Biotech Holding |
4/2008 | Series B | 1 | $42.9M |
dievini Hopp Biotech Holding dievini Hopp Biotech Holding |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|